Indiana University Health Ball Memorial Hospital

Indianapolis, IN
Date of first commercial TAVR procedure performed*:
Mar, 2021
TAVR Total Commercial Volume
Cumulative volume since program inception:
100
Average annual volume for reporting period:
NA- Site did not meet the three-year period reporting requirements.

30-Day Risk Adjusted TAVR Composite ^1,2,3
Reporting Period:
October 1, 2020 through September 30, 2023
Eligible procedures in reporting period:
NA- Site did not meet the three-year period reporting requirements.
TAVR 30 Day Composite Score**:
NA- Site did not meet the three-year period reporting requirements.

TAVR 30-Day Composite Rating**
NA- Site did not meet the three-year period reporting requirements.

* Site may have performed non-commercial/research procedures prior to this date. Non-commercial and research procedures are not reported in the TVT Registry.

** Please view Ratings Explanation for detailed calculation and site rating information.

30-Day Risk Adjustment TAVR Composite consists of six ordered categories based on the worst possible outcome (30-day death} to the best possible outcome (e.g. alive and free of major complications) during hospitalization and the 30-day follow-up period as defined below:

30-day death
30-day stroke
30-day life-threatening/major bleed
Acute kidney injury (stage III}
30-day moderate to severe paravalvular leak
None of the above

The TAVR 30-day mortality/morbidity composite score is reported as a "win difference" where:

>0 implies "My Hospital" has better than expected performance, and
<0 implies "My Hospital" has worse than expected performance

Missing value (shown as 0) indicates that the hospital does not meet eligibility criteria for reporting